Share price is suffering, looks like the nervous Nelly's are in control at present with the low levels of cash at bank, low revenue and still too high cash burn.
Won't really see much change unless the market sees, or is convinced of, a good turnaround from sales of FebriDx and ViraDx. So an update in December/January would be good, otherwise we could be waiting for the end of January for the quarterly report for any potential turnaround.
Share price is suffering, looks like the nervous Nelly's are in...
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
